Drugmakers Seek Clarity on Two FDA Labeling Guidances

Drugmakers and industry groups are calling for changes to two recent US Food and Drug Administration (FDA) draft guidances on product labeling, one covering instructions for use (IFU) for drugs, biologics and combination products and the other providing recommendations on drug abuse and dependence labeling.